🔗 Share this article

Acclaimed R&B singer D’Angelo passed away on the fourteenth of October at age 51 after a personal fight with pancreatic cancer.

“The shining star of our family has dimmed his light for us in the present world,” his family confirmed. “After a prolonged and brave struggle with the disease, we are heartbroken to declare that Michael D’Angelo Archer, recognized by his fans around the world as D’Angelo, has been called home.”

D’Angelo left an indelible mark on music with his innovative modern soul style and collaborations with renowned musicians.

He launched his debut album, “Brown Sugar,” in 1995 to immediate acclaim. The record reached No. 4 on the R&B charts, went platinum later that year, and earned several Grammy nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that propelled his artistic journey into the limelight. The record premiered at the top spot on each of the R&B charts and the main album chart. He won two Grammys: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a sex symbol, albeit a reluctant one, in the cultural zeitgeist. The intimate portrayal showed the artist, famously stripped down to his waist, singing straight into the camera.

D’Angelo stepped back from the spotlight after releasing Voodoo and openly battled with substance abuse. In 2005, he was part of a serious car crash that left him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), confirmed his enduring appeal with a further No. 1 debut on the R&B chart and a award for Best R&B Album.

Again, in his own enigmatic way, D’Angelo had limited public appearances in the following years.

The musician was announced as a top act for the 2025 Roots Picnic festival, but his appearance was called off, citing an “unexpected health issue.”

Even though details are sparse about D’Angelo’s health in the months before his passing, he had apparently been hospitalized for an extended period and in palliative care for two weeks.

D’Angelo’s passing is a clear example of the harmful impact of pancreatic malignancy, one of the most deadly and least preventable forms of the disease, on a brilliant talent whose life was ended too soon.

“We are grieved that he can only leave dear memories with his loved ones, but we are eternally grateful for the heritage of extraordinarily moving music he has left us,” his kin expressed.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic malignancy affects the pancreas, a tiny gland that produces the hormone insulin and is vital in digestion, among other functions. The size and location of the organ in the body make it more difficult to detect malignancy.

Although this cancer makes up only about 3% of malignancy cases annually in the United States, it is causes seven percent of malignancy fatalities.

Nearly 70,000 individuals will be found to have this condition and roughly fifty-two thousand will succumb to the illness in the year 2025.

“Pancreatic cancer is one of the deadliest cancers, with an aggressive tumor and poor prognosis. We have few and poor therapies, and a smaller window to make a meaningful impact on the lives of people,” said a medical oncologist.

Because this disease rarely causes early symptoms, it’s often identified only after the condition is advanced. Although a individual has symptoms they are often vague and may be mistaken for a number of everyday ailments.

“Currently, there is no good way to detect pancreatic cancer in the initial phases, except for paying attention to physical changes and speaking with your physician if there are unfamiliar symptoms,” said a health expert.

Frequent indicators of this disease encompass:

• discomfort in the stomach or back
• weight loss
• yellowing of skin and eyes
• reduced hunger
• brownish urine
• pale or fatty bowel movements
• loose stools
• excessive hunger or thirst
• feeling sick

At age 51, D’Angelo’s death is an outlier, as pancreatic cancer is typically found in individuals in the 65 to 75 range. However, numerous malignancies, such as pancreatic cancer, have become more common in younger people.

“Pancreatic cancer diagnosed before the age of 50 is considered rare, yet concerningly, clinicians are noticing a rising count of younger patients affected by this condition,” said a specialist.

Genetic Background Impacts Cancer Risk

Without effective detection methods for this malignancy, experts emphasized the significance of knowing your relatives’ health background. Certain risk factors, such as tobacco use and obesity also have an influence in the development of pancreatic cancer.

African Americans have the greatest occurrence of pancreatic cancer in the U.S. and are more prone to be diagnosed with untreatable disease.

“The initial action toward lowering one’s risk of pancreatic cancer is understanding individual susceptibility. Individuals should examine their family history, hereditary factors, and health issues, such as blood sugar disease, long-term pancreas inflammation, or overweight that may raise their susceptibility,” advised a specialist.

Inherited genetic risk factors are associated with as much as ten percent of all pancreatic cancer cases. If someone in your household has had pancreatic cancer, you may want to think about DNA analysis.

“For people with a relative’s background of pancreatic cancer or those having high risk DNA changes, checking may involve sophisticated scans such as MRI scans or internal ultrasound to find early changes in the pancreas,” he explained.

For those looking to lower their chance, lifestyle changes may make a difference. The best action you can take to reduce your susceptibility of this disease is to stop tobacco use, and if you don’t smoke, stay away altogether.

Heavy drinking is associated with pancreatitis, a risk factor for pancreatic cancer, so limiting or avoiding drinks may assist lower your chance.

Managing your body mass or shedding pounds may also aid decrease your susceptibility. Individuals with obesity are 20% more likely to get pancreatic cancer. This malignancy also is more frequent in people with blood sugar issues, and reducing weight can also lower the chance of adult-onset diabetes.

In spite of pancreatic cancer’s grim outlook, there is still hope.

“We are doing better with therapies and newer mixed drug treatments. There are developing precision medicines that already are showing results,” remarked a expert.

For numerous people, however, awareness about this rare but {dev